This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
3 days in-person. 3 days virtually.
October 24–26, 2022 | Leipzig, GermanyNovember 2–4, 2022 | Virtual

Charlotte Smerdon
Cell & Gene Centre of Excellence Lead, Portfolio Director Project Management at Veristat

Profile

Charlotte Smerdon, PhD., brings more than 15 years of industry experience across all phases of clinical development encompassing NDA submissions, approval and post-approval initiatives. She began her career as a clinical research associate and subsequently moved onto various roles of increasing responsibility in the biotech, pharma, and CRO sectors, across multiple therapeutic areas and global geographies. Freeline, Gilead, GSK CH, Amgen, TAKEDA and Servier were some of the organizations where Charlotte put her expertise to work, providing leadership for trial deliverables involving project management, clinical monitoring, site management, clinical data management, SAS programming, biostatistics, pharmacovigilance, regulatory affairs and medical writing, with a focus on financial controls and compliance.

She possesses a wealth of knowledge in complex high profile clinical trial programs and portfolios across diverse therapeutic areas including gene therapy, rare diseases, HIV, and Covid-19 among others. Charlotte’s geographic experience includes the US, EMEA, UK, South America, Canada, APAC and Japan, with hands-on expertise working with regulatory authorities in each region. Charlotte is currently Director of Veristat’s Cell & Gene Center of Excellence and Portfolio Director of Veristat’s EU project management team. She holds a BSc with honours from the University of Hertfordshire and a PhD from University College, London.

Charlotte Smerdon's Network

Agenda Sessions

  • From bench to bedside: the unique clinical pathway of CGT products

    13:00

Speakers at this event